GlassScriptPhysician profile
David R Brandau
NPI 1154317840
$827.61
in general payments reported to CMS, 2019-2025
20 companies · $18.99 in 2025
The $18.99 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $125 · 2021: $115 · 2022: $25.50 · 2023: $49.00 · 2024: $32.45 · 2025: $18.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $229.45 | 2019-2025 | Orilissa, Botox |
| Allergan, INC. | $114.68 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $90.35 | 2019 | |
| Exeltis, USA INC. | $63.34 | 2020-2023 | Slynd |
| Therapeuticsmd, INC. | $39.83 | 2019-2020 | |
| Hologic Sales and Service, LLC | $38.82 | 2019-2020 | |
| Lupin INC. | $34.80 | 2019-2020 | |
| Coopersurgical, INC. | $25.42 | 2021-2022 | |
| Roche Diagnostics Corporation | $24.52 | 2019 | |
| Astellas Pharma US INC | $23.80 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $18.32 | 2024 | Gemtesa |
| Evofem Biosciences, INC. | $16.33 | 2021 | |
| Convatec INC. | $15.44 | 2020 | |
| Minerva Surgical, INC | $14.50 | 2019 | |
| Mission Pharmacal Company | $14.22 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $13.60 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.41 | 2019 | |
| Abbott Laboratories | $12.74 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $12.58 | 2019 | |
| Avion Pharmaceuticals | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Brandau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.